We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
151 hedge funds and large institutions have $210M invested in Puma Biotechnology in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
34,850% more call options, than puts
Call options by funds: $699K | Put options by funds: $2K
136% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 14
37% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 38
15% more capital invested
Capital invested by funds: $183M → $210M (+$27.7M)
14% more funds holding
Funds holding: 132 → 151 (+19)
1.89% more ownership
Funds ownership: 68.26% → 70.14% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
151
Holders Change
+19
Holders Change %
+14.39%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
33
Increased
52
Reduced
38
Closed
14
Calls
$699K
Puts
$2K
Net Calls
+$697K
Net Calls Change
-$1.03M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$2.97M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.85M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.81M |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$1.55M |
| 5 |
RWM
Ritholtz Wealth Management
New York
|
+$1.19M |
